This month, the FDA authorized state-licensed pharmacists to prescribe Paxlovid to eligible patients with COVID-19. According to the director for the FDA’s Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., this new limited authorization should allow...
One year ago today the World Health Organization first called the COVID-19 outbreak, a pandemic. The restrictions that were slowly taking over the US turned into a full-blown shutdown. Zipnosis, like many other organizations across the country, closed the office for...
In the last nine months, I have watched the Zipnosis team dive deep into COVID-19 work with incredible dedication. Adoption to virtual care is no longer an option, and I can say with certainty the work being done will lead to more efficient and higher quality...
Last month on our blog we talked about how implementing a telemedicine platform can help recover revenue lost due to COVID-19. Many people have delayed annual visits and elective procedures while also avoiding care for acute needs. This shift has caused significant...
Last week, Jon talked about how health systems can, and must, see virtual care as a part of their long term success. Virtual care isn’t a temporary fix—it’s a longstanding solution. But what does that solution actually look like in practice? For some, this can be...
Over the past few weeks, I’ve been thinking a lot about what the rest of 2020 will look like for healthcare. Right now, health systems have the opportunity to make virtual care a part of their success story, instead of just using it as a COVID-19 band-aid. Here are...
